BamSEC and AlphaSense Join Forces
Learn More

Eli Lilly and Company

NYSE: LLY    
Share price (11/22/24): $748.01    
Market cap (11/22/24): $710 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from SC 13D/A 3 pages Lilly Completes Acquisition of Sigilon Therapeutics
12/34/56
EX-2.2
from SC 13D 15 pages Tender and Support Agreement
12/34/56
EX-2.6
from SC 13D/A 3 pages Lilly Completes Acquisition of Akouos Expanding Efforts to Help People With Genetic Diseases
12/34/56
EX-2.2
from 10-K 48 pages First Amendment to Stock and Asset Purchase Agreement
12/34/56
EX-2
from 10-Q 109 pages Novartis AG and Eli Lilly and Company Stock and Asset Purchase Agreement Between Novartis AG and Eli Lilly and Company Dated as of April 22, 2014 Contents
12/34/56
EX-2.2
from SC 13D 3 pages Confidentiality Agreement
12/34/56
EX-2.1
from SC 13D 28 pages Stock Purchase Agreement Between Eli Lilly and Company (The “Purchaser”) and United Therapeutics Corporation (The “Company”), Dated as of November 14, 2008
12/34/56
EX-2.1
from 8-K 87 pages Agreement and Plan of Merger Among Eli Lilly and Company, Alaska Acquisition Corporation and Imclone Systems Incorporated Dated as of October 6, 2008
12/34/56
EX-2.1
from SC TO-C 87 pages Agreement and Plan of Merger Among Eli Lilly and Company, Alaska Acquisition Corporation and Imclone Systems Incorporated Dated as of October 6, 2008
12/34/56
EX-2
from SC 13D ~5 pages Form of Voting and Support Agreement
12/34/56
EX-2.1
from 8-K ~50 pages Stock Purchase Agreement
12/34/56
EX-2.5
from S-4 1 page Form of Proxy for Ims
12/34/56
EX-2.3
from S-4 1 page Form of Support Agreement Dtd 8/2/95
12/34/56
EX-2.1
from S-4 ~50 pages Agreement and Plan of Merger Dtd 8/2/95
12/34/56